A sense of urgency, powerful science, relentless ingenuity, hope and trust drove the development of Pfizer and BioNTech’s mRNA vaccine during the height of the Covid-19 pandemic. As the crisis appears to lessen, Pfizer is preparing for the next pandemic.

AstraZeneca said a late-stage trial failed to provide evidence that the company’s Covid-19 antibody therapy protected people who had contact with an infected person from the disease, a small setback in its efforts to find alternatives to vaccines.

The head of the EU drug regulator’s Covid-19 task force said on June 13 that AstraZeneca’s coronavirus vaccine had a favorable risk-benefit profile for all age groups and particularly for those aged over 60.

Europe’s drug regulator on June 11 identified another rare blood condition as a potential side effect of AstraZeneca’s Covid-19 vaccine and said it was looking into cases of heart inflammation after inoculation with all coronavirus shots.

British life sciences company NetScientific Plc said on June 7 that one of the company’s subsidiaries entered an exclusive licensing agreement with AstraZeneca Plc to globally sell a Covid-19 test.

AstraZeneca Plc’s drug Lynparza reduced the risk of relapse and death in breast cancer patients with certain mutations in a late-stage trial, the British drugmaker said on June 3.

The Russian health ministry’s ethical committee declined to approve clinical trials in Russia combining a British shot from AstraZeneca and Oxford University with Russia’s Sputnik V vaccine, an AstraZeneca official told Reuters on May 28.

AstraZeneca’s top-selling Tagrisso drug was approved for use in the European Union to treat patients with a type of early-stage lung cancer, the company said on May 28.

Taiwan directly accused China for the first time on May 26 of blocking a deal with Germany’s BioNTech SE for Covid-19 vaccines, in an escalating war of words after Beijing offered the shots to the island via a Chinese company.

A lawyer for the European Union accused AstraZeneca on May 26 of failing to respect the company’s contract with the 27-nation bloc for the supply of Covid-19 vaccines and asked a Belgian court to impose a large fine on the Anglo-Swedish drug firm.